You are reading the October 2026 edition. Get the current edition for this market — $99/year →

Labor Market Pulse

Binghamton, NY Metro Edition

Focus: LIFE SCI

Binghamton life sci talent competes against a record-tight NY market.

4.4%

Binghamton metro unemployment

Steady since July 2026; vs 4.3% NY state

23,643

NY pharma/biotech jobs

Record high, Aug 2026 statewide

-39% YoY

BioSpace job postings

Signals selective, specialty-focused hiring

$97,647

CRA advertised pay, metro

vs $90,956 national median, both rising

This Month's Takeaways

01

Selective national hiring masks local vulnerability to poaching.

BioSpace postings down 39% year-over-year reflects tighter, more targeted hiring nationally, but New York's 38,700 life sciences research professionals remain the largest pool in the country — a magnet pulling Binghamton-based regulatory and quality talent toward higher-paying downstate and Boston-area roles.

02

CRA pay surge signals execution roles are no longer cheap insurance.

Metro median CRA pay at $97,647 outpaces the national median of $90,956, both trending up significantly — a sign that even mid-tier clinical operations roles are being bid up as sponsors and CROs compete for dwindling monitoring capacity.

03

Regional wage base makes build-vs-outsource math harder to ignore.

Broome County's roughly $37,000 average wage sits far below the life sciences national base salary range, meaning internal hires for specialized CMC or regulatory functions require premiums well above local norms — a gap that may tilt headcount decisions toward CDMO/CRO partnerships rather than in-house builds.

04

Healthcare-dominant local economy limits scientific labor supply.

With healthcare and social assistance accounting for 16% of Binghamton's private employment and manufacturing stable near 10,000 workers, the metro's labor base skews toward clinical care delivery rather than life sciences R&D or manufacturing — reinforcing reliance on imported or remote specialized talent.

Binghamton metro unemployment held steady at 4.4% in August against a backdrop of modest regional job growth, with employed residents up 1,500 to 103,800, while healthcare and social assistance remains the dominant local employer base at 16% of private employment. Statewide, New York's life sciences sector hit a record 23,643 pharma and biotech jobs even as BioSpace postings fell 39% year-over-year, signaling employers are hiring selectively and concentrating offers on scarce, credentialed specialties rather than broadening headcount.

Broome County's thin specialized talent base — concentrated in a healthcare-heavy, lower-wage regional economy where average wages sit near $37,000 against a statewide life sciences environment paying mid-$140K to low-$160K base salaries — means local employers face a structural pay gap when competing for regulatory, quality, or CMC talent against Albany, Boston, or metro NYC sites. National CRA advertised pay climbed to a metro median of $97,647, up significantly from $90,956 nationally, suggesting even execution-level clinical roles now command premiums that strain a thin regional labor pool. Current conditions suggest reviewing whether Binghamton-based clinical, quality, and regulatory roles need geographic pay differentials or remote-eligible structuring to remain competitive against higher-cost hubs drawing the same limited candidate pipeline.

Advertised Pay Indicators

Role P25 Median P75 Local Trend National Nat. Trend
Research Scientist — — — — No data $131,354 ↑ Significant increase
Clinical Research Associate $72,812 $97,647 $102,276 ↑ Significant increase $90,956 ↑ Significant increase
Lab Technician — — — — No data $47,402 ↓ Moderate decline
Regulatory Affairs Specialist — — — — No data $104,000 → Stable
Clinical Data Manager — — — — No data $123,031 ↓ Moderate decline
Biostatistician — — — — No data $133,322 ↑ Moderate increase
Validation Engineer — — — — No data $108,377 ↑ Moderate increase

Some roles reflect state-level data where local metro sample size was insufficient.

Looking Ahead · Next 30–60 Days

Worth watching

September's national biopharma layoffs (BioMarin, Bristol Myers) concentrated in consolidation functions rather than execution roles; watch whether any displaced regulatory or quality talent filters into the Binghamton/Southern Tier candidate pool over the next two months.

Emerging pressure point

New York's record 23,643 pharma/biotech jobs statewide, paired with falling postings volume, suggests employers are consolidating demand into fewer, more senior roles — a dynamic that could widen the compensation gap between upstate sites like Binghamton and downstate hubs.

Early indicator

National CRA advertised pay rising significantly in both metro and national medians may foreshadow similar upward pressure on other clinical operations and quality roles locally; organizations should track whether neighboring Albany or Rochester postings begin reflecting comparable increases.

Potential inflection point

WARN activity remains low statewide with no large-scale layoffs reported regionally, but Binghamton's heavy healthcare employment concentration means any shift in hospital system staffing (Guthrie, UHS) could quickly affect the broader clinical talent pool life sciences employers also draw from.

WageScape Member Benefit

Monitor more markets, industries, and job families.

Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.

Pulse Plus

3 metro reports

$149/year

Pulse Pro

10 metro reports

$349/year

Enterprise

10+ markets

Contact us

WageTrak · 15% Member Discount

On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.

Forwarded This Briefing?

Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.